Reengineered salivary glands are stable endogenous bioreactors for systemic gene therapeutics

The use of critical-for-life organs (e.g., liver or lung) for systemic gene therapeutics can lead to serious safety concerns. To circumvent such issues, we have considered salivary glands (SGs) as an alternative gene therapeutics target tissue. Given the high secretory abilities of SGs, we hypothesi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Voutetakis, Antonis, Kok, Marc R., Zheng, Changyu, Bossis, Ioannis, Wang, Jianghua, Cotrim, Ana P., Marracino, Natanya, Goldsmith, Corinne M., Chiorini, John A., Loh, Y. Peng, Nieman, Lynnette K., Baum, Bruce J.
Format: Artigo
Idioma:Inglês
Publicat: National Academy of Sciences 2004
Matèries:
Biological Sciences
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC365743/
https://ncbi.nlm.nih.gov/pubmed/14978265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0400136101
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars